David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Beijing’s Backing Should Bring Relief to Pinduoduo Investors

By David Moadel, InvestorPlace Contributor

Overseas investing can be risky, but the rewards with PDD stock may be substantial as Pinduoduo provides a unique e-commerce experience.

Despite Choppy Waters, Royal Caribbean Cruises Is Ready to Set Sail

By David Moadel, InvestorPlace Contributor

Two years after the crash, RCL stock still has catching up to do but Royal Caribbean is working diligently to return to full operations.

Play the Tech-Stock Bottoming Process With Apple Stock

By David Moadel, InvestorPlace Contributor

You can spend your time worrying about the implications of a rising Fed funds rate - or, you can just enjoy steady profits with AAPL stock.

Why Novavax Stock Is Due for a Comeback Soon

By David Moadel, InvestorPlace Contributor

As Novavax has its Covid-19 vaccine authorized in multiple major world markets, NVAX stock is overdue for a re-rating on Wall Street.

New Platform Features Will Get Robinhood Stock Back on Track

By David Moadel, InvestorPlace Contributor

Even though Robinhood started a revolution in the financial markets, HOOD stock remains out of favor, but this is a contrarian opportunity.

Bionano Genomics Stock Can Regain the Crucial $5 Level

By David Moadel, InvestorPlace Contributor

Bionano Genomics is working hard to address rare diseases, yet Wall Street doesn't see the value in BNGO stock -- but that could change soon.

Don’t Underestimate the Upside Potential of Digital World Acquisition

By David Moadel, InvestorPlace Contributor

DWAC stock is controversial and not appropriate for everyone, but betting against it could be a portfolio-wrecking misjudgment.

Capture Profits in New Digital Worlds With Matterport Stock

By David Moadel, InvestorPlace Contributor

MTTR stock has fallen below its IPO price, but that's not a sell signal as Matterport demonstrates powerful platform subscriber growth.

Clover Health Stock Will Be Your Lucky Four-Leaf Clover in 2022

By David Moadel, InvestorPlace Contributor

CLOV stock is high-risk but potentially also high-reward as Clover Health rakes in the revenue and helps at-risk patients get healthcare.

What’s So Special About Clover Health?

By David Moadel, InvestorPlace Contributor

As many underserved U.S. seniors seek affordable healthcare, CLOV stock is transforming an entire industry through data and technology.

Load More